Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
RX-5902 Treatment of Subjects With Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02003092. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nadunolimab in Combination with Gemcitabine Plus Carboplatin in Patients with Advanced Triple Negative Breast Cancer.
ClinicalTrials.gov study NCT05181462. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of TQB2450 Injection and Anlotinib Hydrochloride Capsules to Treat Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT03855358. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06434064. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers
ClinicalTrials.gov study NCT05846789. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT01232062. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Zoledronic Acid Combined With EC-T for Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT06876636. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II Study of Triple-negative Breast Cancer Brain Metastases.
ClinicalTrials.gov study NCT04303988. IPD Sharing: NO. Countries: 1. Publications: 0.
Tislelizumab in Combination With Eribulin for Patients With Metastatic Previously heaviLy-treAted TriplE-negative Breast Cancer：A Prospective Multiple-center Phase II Study
ClinicalTrials.gov study NCT04913571. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors
ClinicalTrials.gov study NCT02014337. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02755272. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05555706. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02744053. IPD Sharing: Not stated. Countries: 1. Publications: 0.
"neoBREASTIM": Atezolizumab Plus RP1 Oncolytic Immunotherapy in the NeoAdjuvant Setting of Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT06067061. IPD Sharing: YES. Countries: 1. Publications: 0.
Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast Cancer
ClinicalTrials.gov study NCT04403529. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Home-Based Exercise Program During Neoadjuvant Treatment to Improve Fatigue and Quality of Life in Early HER2-Positive and Triple-Negative Breast Cancer Patients
ClinicalTrials.gov study NCT06782698. IPD Sharing: YES. Countries: 1. Publications: 0.
Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT01069796. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies
ClinicalTrials.gov study NCT03719326. IPD Sharing: YES. Countries: 2. Publications: 0.
CTC Changes and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer
ClinicalTrials.gov study NCT04059003. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02977468. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.